vs
Side-by-side financial comparison of HARROW, INC. (HROW) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $50.3M, roughly 1.8× READING INTERNATIONAL INC). HARROW, INC. runs the higher net margin — 7.4% vs -5.1%, a 12.5% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -14.2%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $4.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.6%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
HROW vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $50.3M |
| Net Profit | $6.6M | $-2.6M |
| Gross Margin | 79.3% | — |
| Operating Margin | 17.5% | -1.9% |
| Net Margin | 7.4% | -5.1% |
| Revenue YoY | 33.3% | -14.2% |
| Net Profit YoY | -2.2% | -14.5% |
| EPS (diluted) | $0.20 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $50.3M | ||
| Q3 25 | $71.6M | $52.2M | ||
| Q2 25 | $63.7M | $60.4M | ||
| Q1 25 | $47.8M | $40.2M | ||
| Q4 24 | $66.8M | $58.6M | ||
| Q3 24 | $49.3M | $60.1M | ||
| Q2 24 | $48.9M | $46.8M | ||
| Q1 24 | $34.6M | $45.1M |
| Q4 25 | $6.6M | $-2.6M | ||
| Q3 25 | $1.0M | $-4.2M | ||
| Q2 25 | $5.0M | $-2.7M | ||
| Q1 25 | $-17.8M | $-4.8M | ||
| Q4 24 | $6.8M | $-2.2M | ||
| Q3 24 | $-4.2M | $-7.0M | ||
| Q2 24 | $-6.5M | $-12.8M | ||
| Q1 24 | $-13.6M | $-13.2M |
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 17.5% | -1.9% | ||
| Q3 25 | 20.6% | -0.6% | ||
| Q2 25 | 17.9% | 4.8% | ||
| Q1 25 | -23.5% | -17.2% | ||
| Q4 24 | 19.3% | 2.6% | ||
| Q3 24 | 2.7% | -0.6% | ||
| Q2 24 | 3.1% | -16.4% | ||
| Q1 24 | -20.0% | -16.7% |
| Q4 25 | 7.4% | -5.1% | ||
| Q3 25 | 1.4% | -8.0% | ||
| Q2 25 | 7.8% | -4.4% | ||
| Q1 25 | -37.2% | -11.8% | ||
| Q4 24 | 10.1% | -3.8% | ||
| Q3 24 | -8.6% | -11.7% | ||
| Q2 24 | -13.2% | -27.4% | ||
| Q1 24 | -39.2% | -29.4% |
| Q4 25 | $0.20 | $-0.11 | ||
| Q3 25 | $0.03 | $-0.18 | ||
| Q2 25 | $0.13 | $-0.12 | ||
| Q1 25 | $-0.50 | $-0.21 | ||
| Q4 24 | $0.19 | $-0.11 | ||
| Q3 24 | $-0.12 | $-0.31 | ||
| Q2 24 | $-0.18 | $-0.57 | ||
| Q1 24 | $-0.38 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $10.5M |
| Total DebtLower is stronger | $250.0M | $185.1M |
| Stockholders' EquityBook value | $52.4M | $-18.2M |
| Total Assets | $399.5M | $434.9M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $10.5M | ||
| Q3 25 | $74.3M | $8.1M | ||
| Q2 25 | $53.0M | $9.1M | ||
| Q1 25 | $66.7M | $5.9M | ||
| Q4 24 | $47.2M | $12.4M | ||
| Q3 24 | $72.6M | $10.1M | ||
| Q2 24 | $71.0M | $9.3M | ||
| Q1 24 | $76.0M | $7.5M |
| Q4 25 | $250.0M | $185.1M | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | $202.7M | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $-18.2M | ||
| Q3 25 | $47.0M | $-12.1M | ||
| Q2 25 | $49.7M | $-7.7M | ||
| Q1 25 | $56.5M | $-8.1M | ||
| Q4 24 | $69.7M | $-4.4M | ||
| Q3 24 | $58.0M | $1.6M | ||
| Q2 24 | $58.5M | $6.5M | ||
| Q1 24 | $60.6M | $18.0M |
| Q4 25 | $399.5M | $434.9M | ||
| Q3 25 | $363.1M | $435.2M | ||
| Q2 25 | $345.0M | $438.1M | ||
| Q1 25 | $364.2M | $441.0M | ||
| Q4 24 | $389.0M | $471.0M | ||
| Q3 24 | $351.5M | $495.7M | ||
| Q2 24 | $306.6M | $494.9M | ||
| Q1 24 | $295.5M | $494.9M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $4.3M |
| Free Cash FlowOCF − Capex | $8.1M | $4.1M |
| FCF MarginFCF / Revenue | 9.1% | 8.2% |
| Capex IntensityCapex / Revenue | 0.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $4.3M | ||
| Q3 25 | $16.6M | $295.0K | ||
| Q2 25 | $-803.0K | $1.6M | ||
| Q1 25 | $19.7M | $-7.7M | ||
| Q4 24 | $-17.8M | $8.0M | ||
| Q3 24 | $3.0M | $1.3M | ||
| Q2 24 | $-2.7M | $-10.4M | ||
| Q1 24 | $-4.6M | $-2.8M |
| Q4 25 | $8.1M | $4.1M | ||
| Q3 25 | $16.4M | $-246.0K | ||
| Q2 25 | $-969.0K | $1.2M | ||
| Q1 25 | $19.5M | $-8.0M | ||
| Q4 24 | $-18.3M | $7.0M | ||
| Q3 24 | $2.3M | $-1.1M | ||
| Q2 24 | $-3.1M | $-10.6M | ||
| Q1 24 | $-4.7M | $-4.7M |
| Q4 25 | 9.1% | 8.2% | ||
| Q3 25 | 22.9% | -0.5% | ||
| Q2 25 | -1.5% | 1.9% | ||
| Q1 25 | 40.8% | -19.8% | ||
| Q4 24 | -27.4% | 12.0% | ||
| Q3 24 | 4.8% | -1.8% | ||
| Q2 24 | -6.3% | -22.7% | ||
| Q1 24 | -13.6% | -10.4% |
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.3% | 1.0% | ||
| Q2 25 | 0.3% | 0.6% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.8% | 1.7% | ||
| Q3 24 | 1.2% | 4.0% | ||
| Q2 24 | 0.7% | 0.5% | ||
| Q1 24 | 0.3% | 4.3% |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
